QQQ   354.92 (-1.75%)
AAPL   172.40 (-0.78%)
MSFT   313.39 (-2.61%)
META   300.94 (-1.92%)
GOOGL   132.43 (-1.30%)
AMZN   124.72 (-3.66%)
TSLA   246.53 (-2.02%)
NVDA   435.17 (-2.82%)
NIO   8.61 (-2.05%)
BABA   84.57 (-2.27%)
AMD   100.08 (-3.09%)
T   14.79 (+0.82%)
F   12.07 (-1.95%)
MU   67.83 (-0.19%)
CGC   0.68 (-6.82%)
GE   107.77 (-0.94%)
DIS   79.54 (-2.61%)
AMC   7.86 (-3.56%)
PFE   33.90 (-0.12%)
PYPL   57.30 (-2.15%)
NFLX   376.75 (-0.94%)
QQQ   354.92 (-1.75%)
AAPL   172.40 (-0.78%)
MSFT   313.39 (-2.61%)
META   300.94 (-1.92%)
GOOGL   132.43 (-1.30%)
AMZN   124.72 (-3.66%)
TSLA   246.53 (-2.02%)
NVDA   435.17 (-2.82%)
NIO   8.61 (-2.05%)
BABA   84.57 (-2.27%)
AMD   100.08 (-3.09%)
T   14.79 (+0.82%)
F   12.07 (-1.95%)
MU   67.83 (-0.19%)
CGC   0.68 (-6.82%)
GE   107.77 (-0.94%)
DIS   79.54 (-2.61%)
AMC   7.86 (-3.56%)
PFE   33.90 (-0.12%)
PYPL   57.30 (-2.15%)
NFLX   376.75 (-0.94%)
QQQ   354.92 (-1.75%)
AAPL   172.40 (-0.78%)
MSFT   313.39 (-2.61%)
META   300.94 (-1.92%)
GOOGL   132.43 (-1.30%)
AMZN   124.72 (-3.66%)
TSLA   246.53 (-2.02%)
NVDA   435.17 (-2.82%)
NIO   8.61 (-2.05%)
BABA   84.57 (-2.27%)
AMD   100.08 (-3.09%)
T   14.79 (+0.82%)
F   12.07 (-1.95%)
MU   67.83 (-0.19%)
CGC   0.68 (-6.82%)
GE   107.77 (-0.94%)
DIS   79.54 (-2.61%)
AMC   7.86 (-3.56%)
PFE   33.90 (-0.12%)
PYPL   57.30 (-2.15%)
NFLX   376.75 (-0.94%)
QQQ   354.92 (-1.75%)
AAPL   172.40 (-0.78%)
MSFT   313.39 (-2.61%)
META   300.94 (-1.92%)
GOOGL   132.43 (-1.30%)
AMZN   124.72 (-3.66%)
TSLA   246.53 (-2.02%)
NVDA   435.17 (-2.82%)
NIO   8.61 (-2.05%)
BABA   84.57 (-2.27%)
AMD   100.08 (-3.09%)
T   14.79 (+0.82%)
F   12.07 (-1.95%)
MU   67.83 (-0.19%)
CGC   0.68 (-6.82%)
GE   107.77 (-0.94%)
DIS   79.54 (-2.61%)
AMC   7.86 (-3.56%)
PFE   33.90 (-0.12%)
PYPL   57.30 (-2.15%)
NFLX   376.75 (-0.94%)
CVE:KNE

Kane Biotech (KNE) Stock Forecast, Price & News

C$0.08
0.00 (0.00%)
(As of 05:20 PM ET)
Compare
Today's Range
C$0.08
C$0.08
50-Day Range
C$0.07
C$0.09
52-Week Range
C$0.07
C$0.15
Volume
1,000 shs
Average Volume
44,615 shs
Market Capitalization
C$9.86 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

KNE stock logo

About Kane Biotech (CVE:KNE) Stock

Kane Biotech Inc., a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. The company develops pet oral care products under the StrixNB and bluestem brands; and animal and human wound care solutions under the DispersinB name. It also offers scalp care products under the DermaKB brand name; and wound care products under the Coactiv+ brand name, as well as other products under the goldstem, silkstem, Aledex, and DermaKB Biofilm brand names. Kane Biotech Inc. was incorporated in 2001 and is based in Winnipeg, Canada.

KNE Price History

KNE Stock News Headlines

Buy THIS stock before Taiwan is attacked
... If the United States goes to war with another nuclear armed superpower, this could have a devastating impact on your retirement portfolio. Now, even Taiwan's own foreign minister is saying that China is on the cusp of a full scale invasion. But the good news is, if China invades Taiwan, there is a way to protect yourself.
Closing Bell: Kane Biotech Inc down on Thursday (KNE)
Buy THIS stock before Taiwan is attacked
... If the United States goes to war with another nuclear armed superpower, this could have a devastating impact on your retirement portfolio. Now, even Taiwan's own foreign minister is saying that China is on the cusp of a full scale invasion. But the good news is, if China invades Taiwan, there is a way to protect yourself.
Closing Bell: Kane Biotech Inc up on Monday (KNE)
Closing Bell: Kane Biotech Inc down on Friday (KNE)
Closing Bell: Kane Biotech Inc up on Wednesday (KNE)
Closing Bell: Kane Biotech Inc flat on Friday (KNE)
Closing Bell: Kane Biotech Inc up on Thursday (KNE)
Closing Bell: Kane Biotech Inc down on Tuesday (KNE)
Closing Bell: Kane Biotech Inc flat on Monday (KNE)
Closing Bell: Kane Biotech Inc down on Wednesday (KNE)
Closing Bell: Kane Biotech Inc up on Friday (KNE)
Closing Bell: Kane Biotech Inc up on Tuesday (KNE)
Closing Bell: Kane Biotech Inc down on Monday (KNE)
See More Headlines
Receive KNE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Kane Biotech and its competitors with MarketBeat's FREE daily newsletter.

KNE Company Calendar

Last Earnings
8/29/2023
Today
10/03/2023
Next Earnings (Estimated)
11/23/2023

Industry, Sector and Symbol

Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Net Income
C$-3,950,000.00
Net Margins
-152.21%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$2.60 million
Cash Flow
C$0.01 per share
Book Value
C($0.07) per share

Miscellaneous

Free Float
N/A
Market Cap
C$9.86 million
Optionable
Not Optionable
Beta
0.22
The Best High-Yield Dividend Stocks for 2023 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

  • Mr. Marc Edwards
    Pres, CEO & Director
  • Mr. Ray Dupuis
    Chief Financial Officer
  • Mr. Kevin Cole
    Pres & CEO of STEM Animal Health Inc
  • Dr. Gregory S. Schultz Ph.D. (Age 73)
    Chief Scientific Officer & Member of Scientific Advisory Board
  • Lorne Gorber
    Investor Relations
  • Ms. Lori Christofalos
    VP of Quality & Compliance
  • Ms. Wendy Nachtigall
    Director of Marketing
  • Nicole Sendey
    Investor Relations Adviser
  • Mr. Mark Ahrens-Townsend
    Advisor













KNE Stock - Frequently Asked Questions

How have KNE shares performed in 2023?

Kane Biotech's stock was trading at C$0.09 at the beginning of the year. Since then, KNE stock has decreased by 16.7% and is now trading at C$0.08.
View the best growth stocks for 2023 here
.

When is Kane Biotech's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 23rd 2023.
View our KNE earnings forecast
.

How were Kane Biotech's earnings last quarter?

Kane Biotech Inc. (CVE:KNE) announced its quarterly earnings results on Tuesday, August, 29th. The company reported ($0.01) earnings per share (EPS) for the quarter. The business had revenue of $0.66 million for the quarter.

What is Kane Biotech's stock symbol?

Kane Biotech trades on the Canadian Venture Exchange (CVE) under the ticker symbol "KNE."

How do I buy shares of Kane Biotech?

Shares of KNE stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Kane Biotech's stock price today?

One share of KNE stock can currently be purchased for approximately C$0.08.

How much money does Kane Biotech make?

Kane Biotech (CVE:KNE) has a market capitalization of C$9.86 million and generates C$2.60 million in revenue each year. The company earns C$-3,950,000.00 in net income (profit) each year or C($0.03) on an earnings per share basis.

How can I contact Kane Biotech?

Kane Biotech's mailing address is 162-196 Innovation Dr, WINNIPEG, MB R3T 6C5, Canada. The official website for the company is www.kanebiotech.com. The company can be reached via phone at +1-204-4531301.

This page (CVE:KNE) was last updated on 10/3/2023 by MarketBeat.com Staff

My Account -